EDAP EDAP TMS SA

CIK 0001041934 10 ready 8-Ks latest August 11, 2026, 5:04 PM ET RSS · JSON

Activity: NORMAL 1 filings / 30d vs 1 baseline

Ready 8-Ks 10

Latest filing August 11, 2026, 5:04 PM ET

Top materiality 0.80

Event mix earnings ×4 · other_material ×4 · debt ×1

Sentiment 3 pos · 0 neg · 7 neu

Latest earnings reported 2026-Q1

Recent 8-K filings for EDAP

Highest-materiality recent filing

FocalTherics reports preliminary Q2 2026 HIFU revenue $12.7-13.2M, up 34-39% YoY; ESWL held for sale

August 11, 2026, 5:04 PM ET earnings materiality 0.80 positive item 2.02 item 8.01 item 7.01 item 9.01

Q2 2026 HIFU revenue $12.7M-$13.2M (+34-39% YoY); gross margin 54-56% (+3-5 pts); operating loss ($8.5M)-($7.5M).
ESWL and Distribution segments classified as discontinued operations/held for sale; HIFU reported as continuing operations.

Read filing →

August 11, 2026, 5:04 PM ET earnings materiality 0.80 positive item 2.02 item 8.01 item 7.01 item 9.01

FocalTherics reports preliminary Q2 2026 HIFU revenue $12.7-13.2M, up 34-39% YoY; ESWL held for sale

Q2 2026 HIFU revenue $12.7M-$13.2M (+34-39% YoY); gross margin 54-56% (+3-5 pts); operating loss ($8.5M)-($7.5M).
June 26, 2026, 4:05 PM ET other material materiality 0.30 neutral item 5.03 item 5.07 item 9.01

EDAP TMS shareholders approve bylaw amendments, reject two say-on-pay frequency options

All six director nominees re-elected; Ryan Rhodes, Lance Willsey, Fran Schulz, Josh Levine, and David Horn confirmed.
June 1, 2026, 4:05 PM ET other material materiality 0.60 neutral item 7.01 item 9.01

EDAP TMS holds FocalTherics Investor Day; plans to exit ESWL and distribution segments to focus on HIFU

Presentation at June 1, 2026 Investor Day highlights strategic shift to High Intensity Focused Ultrasound (HIFU) devices.
May 29, 2026, 7:30 AM ET other material materiality 0.60 neutral item 8.01

EDAP TMS rebrands as FocalTherics, ticker to FOCL June 1; ESWL/Distribution discontinued ops

Corporate name changes to FocalTherics; ticker symbol switches from EDAP to FOCL effective June 1, 2026.
May 7, 2026, 7:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01 ◈ Earnings Releases

EDAP Q1 2026: record HIFU revenue $11.6M (+78% YoY); net loss $9.1M

HIFU revenue $11.6M, up 78% YoY; total revenue $17.8M vs $14.3M in Q1 2025.
April 2, 2026, 7:59 PM ET debt materiality 0.65 neutral item 2.03 item 3.02 ◈ Debt Financings

EDAP TMS draws €12M second tranche from EIB credit facility; issues warrants at €3.23 strike

Drawdown of €12.0 million under Tranche B of EIB credit facility, expected disbursement late April 2026.
March 25, 2026, 7:59 PM ET earnings materiality 0.75 neutral item 2.02 item 9.01 ◈ Earnings Releases

EDAP reports record 2025 HIFU revenue up 39% YoY; net loss widens, FY2026 guidance reaffirmed

HIFU revenue €33.1M in FY2025, +39% YoY; Focal One placements up 69% YoY.
March 18, 2026, 7:59 PM ET other material materiality 0.25 neutral item 7.01 item 9.01

EDAP TMS highlights 87 Focal One installs, 29% procedure CAGR in Oppenheimer presentation

87 Focal One systems installed globally (42 academic, 45 community) as of Dec. 31, 2025.
February 12, 2026, 6:59 PM ET leadership materiality 0.40 neutral item 5.02 item 7.01 item 9.01

EDAP appoints David Horn to Board; Glen French resigns

Glen French resigned from EDAP Board and all committees effective Feb 10, 2026; resignation not due to any dispute.
January 12, 2026, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 7.01 item 9.01

EDAP reports record Q4 HIFU revenue $12.9-13.3M; issues 2026 guidance $50-54M

Q4 HIFU revenue $12.9-13.3M (record); FY2025 HIFU revenue $36.7-37.2M, up 36-38% YoY.

Earnings & guidance

2026-Q1 EPS reported -$0.24 filing →

Materiality & sentiment trend

Max materiality 0.80 · Median 0.62 · Most common event earnings

3 positive 0 negative 7 neutral

source · EDAP on sec.gov